Differences in Clinical Features of Methamphetamine Users with Persistent Psychosis and Patients with Schizophrenia

Abstract

Findings in the current study suggest that nuanced differences might exist in the clinical presentation of secondary psychosis (MAP) and primary psychosis (schizophrenia). Combining the symptoms as a whole may help with differential diagnosis for MAP and schizophrenia.